by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Mark Cuban Cost Plus Drug Co. and the Purchaser Business Group on Health’s EmansaRx jointly launched EmansaRx Plus, a pharmacy benefit manager (PBM) majority-owned by the business group that supplements employers’ existing drug benefits. EmansaRx Plus...
by Jordana Choucair | Dec 9, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized updated COVID-19 shots from Pfizer and Moderna that target the omicron variant for children as young as six months. Children between 6 months and 5 years old who received the Moderna primary series can receive the...
by Jordana Choucair | Dec 9, 2022 | Opioid/Substance Use Disorders
The White House launched a new national dashboard to track non-fatal opioid overdoses and provide first responders, clinicians, and policymakers with real-time, actionable information to improve the country’s response and save lives. The Nonfatal Opioid Overdose...
by Jordana Choucair | Dec 9, 2022 | Payers
A Mercer survey of more than 2,000 companies found that employers expect benefits costs to increase by 5.4 percent next year as health care cost rates catch-up with inflation. Still, most (84 percent) said that “enhancing benefits to improve attraction and...
by Jordana Choucair | Dec 8, 2022 | Access & Coverage
The Centers for Medicare & Medicaid Services (CMS) released new data indicating that 5.5 million people have enrolled in an Affordable Care Act (ACA) marketplace insurance plan in the first five weeks of open enrollment. That figure includes 1.2 million people who...
Recent Comments